The Borrowing. The Bonds.
The Borrowing. For purposes of determining compliance with the conditions specified in Section 5.1, each Lender shall be deemed to have consented to, approved or accepted or to be satisfied with each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to the Lenders unless an officer of the Administrative Agent responsible for the transactions contemplated by this Agreement shall have received notice from such Lender prior to the date that the Borrower, by notice to the Lenders, designates as the proposed Effective Date, specifying its objection thereto. The Administrative Agent shall promptly notify the Lenders of the occurrence of the Effective Date.
The Borrowing. The Loans shall be made initially as LIBOR Loans with an initial Interest Period of one week in the aggregate amount of $300,000,000 on the Closing Date to the account(s) to which the proceeds of the Borrowing are to be credited, as contemplated by Section 2.1.1.3(d).
The Borrowing. For purposes of determining compliance with the conditions specified in Section 5.1, each Lender shall be deemed to have consented to, approved or accepted or to be satisfied with each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to the Lenders unless an officer of the Administrative Agent responsible for the transactions contemplated by this Agreement shall have received notice from such Lender prior to the date that the Borrower, by notice to the Lenders, designates as the proposed Effective Date, specifying its objection thereto. The Administrative Agent shall promptly notify Finnvera and the Lenders of the occurrence of the Effective Date.
The Borrowing. Notes and Bonds of the Authority.
The Borrowing. Subject to the terms and conditions set forth herein, each Lender with a Term Loan Commitment severally agrees to make a loan in Dollars (such loan, a “Term Loan”) to the Borrower on the Closing Date in an aggregate amount not to exceed such Lxxxxx’s Term Loan Commitment. Amounts borrowed under this Section 2.01 and repaid or prepaid may not be reborrowed. The Term Loan may be a Base Rate Loan or a Term SOFR Loan, as further provided herein.
The Borrowing. (a) Subject to the terms and conditions set forth herein, each Lender severally agrees to make to the Borrower a single loan in Dollars in a principal amount equal to such Lender’s Bridge Commitment on the Closing Date. Amounts borrowed under this Section 2.01 and repaid or prepaid may not be reborrowed. Bridge Loans may be Base Rate Loans or Eurocurrency Rate Loans, as further provided herein.
(b) Subject to the terms and conditions set forth herein, the Borrower and each Lender severally agrees, if the Bridge Loans have not been repaid in full on or prior to the Extension Date, that the then-outstanding principal amount of the Bridge Loans shall automatically be converted into term loans (the “Extended Term Loans”) by the Borrower on the Extension Date in an aggregate principal amount equal to the then-outstanding principal amount of the Bridge Loans.
The Borrowing. (a) [Reserved]
i) The Borrowing shall be made on at least two (2) Business Days’ irrevocable written notice from the Borrower to the applicable Lender (such written notice, the “Notice of Borrowing”), provided that such Notice of Borrowing is received by such Lender no later than 12:00 noon (New York City time) on the Business Day of receipt. Any Notice of Borrowing received after 12:00 noon (New York City time) shall be deemed received prior to 12:00 noon (New York City time) on the following Business Day. The Notice of Borrowing shall specify (A) the aggregate amount of the Borrowing, (B) the date of the Borrowing, (C) the allocation of the Loans as Class A Loans and Class B Loans and (D) in an electronic file acceptable to the Lenders, the Eligible Receivables to be Pledged in connection with the Borrowing (and upon the Borrowing, such Receivables shall be Pledged Receivables hereunder). On the date of the Borrowing, upon satisfaction of the applicable conditions set forth in Article III the Class A Lender and the Class B Lender shall make available to the Borrower the portion of the Borrowing constituting the Class A Advance Amount and the Class B Advance Amount, respectively, on the Borrowing Date, no later than 2:00 P.M. (New York City time), in same day funds (net of amounts payable to or for the benefit of each related Lender), by payment into the account which the Borrower has designated in writing.
The Borrowing. 1. The subject matter hereof involves the Lender’s obligation to provide the equipment listed in Attachment No. 1 hereto, total price of the equipment provided (hereinafter the Borrowing) to the Borrower for free use. výpůjčky).
2. Je-li to s ohledem na povahu příslušné položky možné, je nedílnou součástí výpůjčky ke každé jednotlivé položce uvedené v příloze č. 1: - instalační protokol, - doklad o instruktáži (proškolení) obsluhy, - doklad osoby, která je poučena výrobcem k provádění instruktáže daného zdravotnického prostředku (§ 61 zákona č. 268/2014 Sb., o zdravotnických prostředcích), - doklady osob, které jsou proškoleny výrobcem nebo osobou autorizovanou výrobcem k provádění odborné údržby (§ 65 zákona č. 268/2014 Sb., o zdravotnických prostředcích), - český návod k obsluze předmětu výpůjčky 2x (1x pro potřeby pracoviště v listinné podobě, 1x pro potřeby OZT v elektronické podobě)
The Borrowing. 1. The subject matter hereof involves the Lender’s obligation to provide the medical device: Medifuge 230V - Ambient bench-top centrifuge, DualSpin, production No. will be indicated in Transfer Protocol, price CZK 20 000 (VAT included) (hereinafter the Borrowing) to the Borrower for free use.
2. The Borrowing includes: - Instructions to operate the medical device in Czech language (in 2 counterparts: 1 in a documentary form for the worksite, 1 in an electronic form for the Medical Equipment Department); - EC Declaration of Conformity according to Act No. 22/1997 Coll. as amended. For medical devices of Class I sterile, I with measuring function, IIa, IIb or III, EC must bear the Notified Body’s number; - The EC Declaration of Conformity (and/or another document that will form a part of the Borrowing and will be certified by the Lender) must show the class of the medical device and/or of all its components; - The EC Declaration of Conformity (and/or another document that will form a part of the Borrowing and will be a bude potvrzen vypůjčitelem), - pokud se výpůjčka skládá z více samostatných komponent, jsou její součástí platná prohlášení o shodě na všechny komponenty výpůjčky, - na všechny doklady předkládané v jiném než v českém jazyce je součástí výpůjčky též jejich český překlad, za jehož správnost odpovídá půjčitel, - platný protokol o provedené bezpečnostně technické kontrole v souladu se zákonem č. 375/2022 Sb., o zdravotnických prostředcích a diagnostických zdravotnických prostředcích in vitro, - platná revize v souladu se zákonem č. 375/2022 Sb., o zdravotnických prostředcích a diagnostických zdravotnických prostředcích in vitro. Vypůjčitel je oprávněn užívat předmět výpůjčky ode dne předání a instalace. Předmět výpůjčky je zapůjčen po dobu trvání klinického hodnocení, protokol č. OP0595-5 s názvem: Multicentrická, randomizovaná, dvojitě zaslepená studie fáze 3 k posouzení účinnosti a bezpečnosti cefepim/nacubaktamu nebo aztreonam/nacubaktamu v porovnání s imipenem/cilastatinem u dospělých s komplikovanou infekcí močového traktu nebo akutní nekomplikovanou pyelonefritidou, tedy přibližně do 30. listopadu 2024
1. Půjčitel oznámí vypůjčiteli termín převzetí předmětu výpůjčky, a to Odboru zdravotnické certified by the Lender) must show the full address of the Borrowing manufacturer and country of origin; - If the Borrowing consists of more separate components, it must include valid declarations of conformity for all components of the Borrowing; - All...
